Description

  • Subsidiary of Johnson & Johnson, Centocor is a biotechnology company that was founded in Philadelphia in 1979 with an initial goal of developing new diagnostic assays using monoclonal antibody technology.In 1982 Centocor developed their first product approved by the U.S. Food and Drug Administration (FDA) a diagnostic test used to detect the rabies virus, and in that same year transitioned into a publicly traded company. Subsequently, the company moved to a larger facility in Malvern, Pennsylvania (a northwest suburb of Philadelphia). In 1984, Centocor opened an overseas plant in Leiden, the Netherlands.Eighteen years after its foundation, (in 1997), Centocor achieved its first year of operating profitability. In 1998, Centocor divested itself of its diagnostic division and launched its top-selling monoclonal antibody Remicade (infliximab) for its first FDA approved indication in Crohn's Disease. In 1999, Centocor became a wholly owned subsidiary of Johnson & Johnson, the worldwide manufacturer and marketer of healthcare products. Subsequently, Remicade's market has expanded with approvals for rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, and pediatric Crohn's disease. Remicade was approved for plaque psoriasis in September 2006.Centocor also markets ReoPro (abciximab), a biologic agent indicated as an adjunct to coronary angioplasty (PTCA).Since being acquired by Johnson and Johnson, Centocor has increased its annual sales from approximately $500 million to more than $2 billion. During the same period, research and development investment increased from $75 million to more than $300 million.In 2004 Centocor purchased a new manufacturing plant in St. Louis, Missouri, and is currently opening a new manufacturing facility in County Cork, Ireland. The Dutch plant has been expanded substantially with a $250 million investment in additional production facilities, which were opened in 2006.
  • location

    Headquarters:1901 Harrison Ct , Norristown, Pennsylvania, United States

    More
  • Centocor phone

    Phone Number: +1 610-240-8170

  • Centocor website

    Website: https://www.centocor.com

  • Centocor employees

    Employees:877

  • Centocor revenue

    Revenue:> $1B

  • Centocor legal name

    Legal Name:Centocor

  • Centocor's Social Media

    Centocor linkedin
  • done Is this data correct?
  • |  NAICS Code: 541713  |

    Show More
Person level website identification

President for Centocor

Neal Fowler

President

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Neal Fowler

President

Hillary Armitage

Director, Cpmo

Ron Krawczyk

Vice President Trade And Business Operations

Cynthia Guzzo

Vice President, Immunology

Bill Hewitt

Vice President

Frequently Asked Questions regarding Centocor

  • Where are Centocor's Headquarters?

    Centocor's Headquarters are in 1901 Harrison Ct ,Norristown,Pennsylvania,United States

  • What is Centocor's phone number?

    Centocor's phone number is +1 610-240-8170

  • What is Centocor's official website?

    Centocor's official website is https://www.centocor.com

  • What is Centocor's Revenue?

    Centocor's revenue is > $1B

  • What is Centocor's NAICS code?

    Centocor's NAICS code is 541713

  • How many employees are working in Centocor

    Centocor has 877 employees

  • What is Centocor's Industry?

    Centocor is in the industry of Biotechnology

  • Who is Centocor's President?

    Centocor's President is Neal Fowler

Company Directory